JPWO2023118366A5 - - Google Patents
Info
- Publication number
- JPWO2023118366A5 JPWO2023118366A5 JP2024529338A JP2024529338A JPWO2023118366A5 JP WO2023118366 A5 JPWO2023118366 A5 JP WO2023118366A5 JP 2024529338 A JP2024529338 A JP 2024529338A JP 2024529338 A JP2024529338 A JP 2024529338A JP WO2023118366 A5 JPWO2023118366 A5 JP WO2023118366A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- treatment
- hydrate
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163292783P | 2021-12-22 | 2021-12-22 | |
| US63/292,783 | 2021-12-22 | ||
| PCT/EP2022/087342 WO2023118366A1 (en) | 2021-12-22 | 2022-12-21 | Gap junction modulators and their use for the treatment of age-related macular degeneration |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025500123A JP2025500123A (ja) | 2025-01-09 |
| JP2025500123A5 JP2025500123A5 (https=) | 2025-12-25 |
| JPWO2023118366A5 true JPWO2023118366A5 (https=) | 2025-12-25 |
Family
ID=84981302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024529338A Pending JP2025500123A (ja) | 2021-12-22 | 2022-12-21 | ギャップ結合モジュレーターおよび加齢黄斑変性の処置のためのその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250018002A1 (https=) |
| EP (1) | EP4452260B1 (https=) |
| JP (1) | JP2025500123A (https=) |
| CN (1) | CN118450892A (https=) |
| CA (1) | CA3240515A1 (https=) |
| DK (1) | DK4452260T3 (https=) |
| FI (1) | FI4452260T3 (https=) |
| IL (1) | IL313729A (https=) |
| WO (1) | WO2023118366A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202310195D0 (en) * | 2023-07-03 | 2023-08-16 | Hastings Nataly | Method for mitigating symptoms of neurological condition and a system therefor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6259296A (ja) | 1985-09-10 | 1987-03-14 | Green Cross Corp:The | ペプタイド誘導体 |
| IL157447A0 (en) | 2001-02-22 | 2004-03-28 | Zealand Pharma As Zealand Phar | New medical uses of intercellular communication facilitating compounds |
| UA96283C2 (uk) | 2005-12-23 | 2011-10-25 | Зіланд Фарма А/С | Модифіковані міметики лізину |
| PL2468724T3 (pl) | 2006-12-21 | 2016-05-31 | Zealand Pharma As | Synteza związków pirolidynowych |
| JP6989864B2 (ja) * | 2017-05-05 | 2022-02-03 | ジーランド ファーマ，アー／エス | ギャップ結合細胞間コミュニケーションモジュレータ及び糖尿病性眼疾患の治療のためのそれらの使用 |
-
2022
- 2022-12-21 CN CN202280084727.5A patent/CN118450892A/zh active Pending
- 2022-12-21 IL IL313729A patent/IL313729A/en unknown
- 2022-12-21 US US18/708,367 patent/US20250018002A1/en active Pending
- 2022-12-21 CA CA3240515A patent/CA3240515A1/en active Pending
- 2022-12-21 WO PCT/EP2022/087342 patent/WO2023118366A1/en not_active Ceased
- 2022-12-21 DK DK22843707.5T patent/DK4452260T3/da active
- 2022-12-21 FI FIEP22843707.5T patent/FI4452260T3/fi active
- 2022-12-21 EP EP22843707.5A patent/EP4452260B1/en active Active
- 2022-12-21 JP JP2024529338A patent/JP2025500123A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5314931B2 (ja) | 加齢黄斑変性の予防又は治療剤 | |
| JP2008308489A (ja) | ロピニロール又はその塩を有効成分として含有する後眼部疾患の予防又は治療剤 | |
| WO1993024121A1 (fr) | Medicament pour le glaucome | |
| IL292350A (en) | Treatment of ocular diseases using endothelin receptor antagonists | |
| US20060111388A1 (en) | Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye | |
| KR101286883B1 (ko) | 각결막 장애의 예방 또는 치료제 | |
| KR102266014B1 (ko) | 안질환 예방 또는 치료용 점안 조성물 | |
| US7638516B2 (en) | Agent for therapeutic treatment of optic nerve diseases and the like | |
| JP2967523B2 (ja) | 眼病用製薬組成物 | |
| WO2010117077A1 (ja) | シロリムス誘導体を有効成分として含有する網脈絡膜疾患の治療剤 | |
| WO2019024433A1 (zh) | 氨基金刚烷胺单硝酸酯类化合物眼用组合物及其制剂和应用 | |
| TWI868659B (zh) | 無防腐劑的眼科藥物乳劑及其應用 | |
| JPWO2023118366A5 (https=) | ||
| FI4452260T3 (fi) | Aukkoliitoksen modulaattoreita ja niiden käyttö ikään liittyvän silmänpohjan rappeuman hoidossa | |
| US20220062255A1 (en) | Treatment of neurodegenerative eye disease using pridopidine | |
| JPWO2005079792A1 (ja) | 重症糖尿病網膜症の予防又は治療剤 | |
| KR100854058B1 (ko) | 스테로이드를 유효 성분으로 하는 망맥락막 질환 치료제 | |
| JP4150846B2 (ja) | ステロイドを有効成分とする網脈絡膜疾患治療剤 | |
| JP2014521648A (ja) | 網膜疾患を治療するための４−ブロモ−ｎ−（イミダゾリジン−２−イリデン）−１ｈ−ベンゾイミダゾール−５−アミンを含む医薬組成物 | |
| JPH10500130A (ja) | テラゾシンを含有する緑内障治療用医薬組成物 | |
| US20250281472A1 (en) | Ophthalmic composition inhibiting occurrence of n-oxopyridine compound for preventing or treating eye disease | |
| CA2817505C (en) | Pharmaceutical formulation having neuroprotective activity | |
| Rojanapongpun et al. | Medical Therapy in Angle Closure Glaucoma | |
| KR20060118520A (ko) | 각결막장해 치료제 | |
| JPWO2007100079A1 (ja) | 三環性トリアゾロベンゾアゼピン誘導体を含有する、アレルギー性眼疾患またはアレルギー性鼻疾患の予防または治療剤 |